Скачать или смотреть Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science

Martin O’Dea on Biomarkers, Longevity Innovation & the Future of Aging Science

How do we measure and validate longevity interventions? In this conversation, Martin O’Dea discusses the evolving role of biomarkers in aging science, the challenge of standardization, and how innovations in epigenetic clocks, proteomics, and AI-driven diagnostics are shaping the future of healthy longevity.

Topics covered in this interview:
Why biomarkers are critical for proving longevity interventions work
The role of epigenetic clocks, metabolic markers, and proteomics
How longevity clinics and the private sector are driving biomarker adoption
The intersection of AI, longevity science, and healthcare regulation
Future trends in biomarker-based aging research

#longevity #Biomarkers #AgingScience #HealthyLongevity #AIinHealthcare #Healthspan #MartinODea #RichardBarker #AgingResearch #Biotech